|
|
|
|
| LEADER |
02611nam a22004695i 4500 |
| 001 |
978-94-007-4234-5 |
| 003 |
DE-He213 |
| 005 |
20150519174121.0 |
| 007 |
cr nn 008mamaa |
| 008 |
120611s2012 ne | s |||| 0|eng d |
| 020 |
|
|
|a 9789400742345
|9 978-94-007-4234-5
|
| 024 |
7 |
|
|a 10.1007/978-94-007-4234-5
|2 doi
|
| 040 |
|
|
|d GrThAP
|
| 050 |
|
4 |
|a R-RZ
|
| 072 |
|
7 |
|a MBGR
|2 bicssc
|
| 072 |
|
7 |
|a MED000000
|2 bisacsh
|
| 082 |
0 |
4 |
|a 610
|2 23
|
| 245 |
1 |
0 |
|a Midkine: From Embryogenesis to Pathogenesis and Therapy
|h [electronic resource] /
|c edited by Mine Ergüven, Takashi Muramatsu, Ayhan Bilir.
|
| 264 |
|
1 |
|a Dordrecht :
|b Springer Netherlands :
|b Imprint: Springer,
|c 2012.
|
| 300 |
|
|
|a X, 338 p.
|b online resource.
|
| 336 |
|
|
|a text
|b txt
|2 rdacontent
|
| 337 |
|
|
|a computer
|b c
|2 rdamedia
|
| 338 |
|
|
|a online resource
|b cr
|2 rdacarrier
|
| 347 |
|
|
|a text file
|b PDF
|2 rda
|
| 520 |
|
|
|a Carl Edward Sagan’s (1934-1996) one of the famous quatation was “Who are we? We find that we live on an insignificant planet of a humdrum star lost in a galaxy tucked away in some forgotten corner of a universe in which there are far more galaxies than people.“ From past to date, well-known molecules, enzymes, proteins, lipids and carbonhydrates are studied in the pathogenesis of several diseases both as a diagnostic/prognostic biomarker and therapeutic agent. The underlying mechanism of unexplained diseases and failure of therapies are frequently studied with well-known biomarkers, but remain unclear in many cases. As Dr. Sagan said other keys are still waiting to be known in some forgetten corner of a body universe, we find strength to propose that one of them can be the growth factor with cytokine activity named “Midkine” This book summarizes the extensive up-to-date literature overeview with the lastest work of experts about midkine in a detailed format that conveys its role as both a pathologic factor and therapeutic agent.
|
| 650 |
|
0 |
|a Medicine.
|
| 650 |
|
0 |
|a Pharmacy.
|
| 650 |
|
0 |
|a Life sciences.
|
| 650 |
1 |
4 |
|a Biomedicine.
|
| 650 |
2 |
4 |
|a Biomedicine general.
|
| 650 |
2 |
4 |
|a Medicine/Public Health, general.
|
| 650 |
2 |
4 |
|a Life Sciences, general.
|
| 650 |
2 |
4 |
|a Pharmacy.
|
| 700 |
1 |
|
|a Ergüven, Mine.
|e editor.
|
| 700 |
1 |
|
|a Muramatsu, Takashi.
|e editor.
|
| 700 |
1 |
|
|a Bilir, Ayhan.
|e editor.
|
| 710 |
2 |
|
|a SpringerLink (Online service)
|
| 773 |
0 |
|
|t Springer eBooks
|
| 776 |
0 |
8 |
|i Printed edition:
|z 9789400742338
|
| 856 |
4 |
0 |
|u http://dx.doi.org/10.1007/978-94-007-4234-5
|z Full Text via HEAL-Link
|
| 912 |
|
|
|a ZDB-2-SBL
|
| 950 |
|
|
|a Biomedical and Life Sciences (Springer-11642)
|
